Detalhe da pesquisa
1.
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C.
Liver Int
; 37(8): 1122-1127, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28423231